S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran — and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran — and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran — and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran — and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota

Mineralys Therapeutics (MLYS) Short Interest Ratio & Short Volume

$13.01
-0.10 (-0.76%)
(As of 04/12/2024 ET)

Mineralys Therapeutics Short Interest Data

Current Short Volume
850,500 shares
Previous Short Volume
842,100 shares
Change Vs. Previous Month
+1.00%
Dollar Volume Sold Short
$10.98 million
Short Interest Ratio / Days to Cover
5.0
Last Record Date
March 31, 2024
Outstanding Shares
49,630,000 shares
Float Size
17,660,000 shares
Short Percent of Float
4.82%
Today's Trading Volume
64,467 shares
Average Trading Volume
123,754 shares
Today's Volume Vs. Average
52%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Mineralys Therapeutics ?

Sign up to receive the latest short interest report for Mineralys Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MLYS Short Interest Over Time

MLYS Days to Cover Over Time

MLYS Percentage of Float Shorted Over Time

Mineralys Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024850,500 shares $10.98 million +1.0%4.8%5 $12.91
3/15/2024842,100 shares $10.69 million -13.5%5.8%4.9 $12.69
2/29/2024974,000 shares $14.98 million +0.9%6.7%5.5 $15.38
2/15/2024965,500 shares $14.46 million +19.1%6.6%5.2 $14.98
1/31/2024810,400 shares $8.84 million -3.2%4.3%4.3 $10.91
1/15/2024836,900 shares $7.78 million -15.5%4.4%4.8 $9.30
12/31/2023990,600 shares $8.52 million +58.5%5.2%5.8 $8.60
12/15/2023625,100 shares $5.04 million -47.9%3.3%3.6 $8.06
11/30/20231,200,000 shares $7.99 million -6.3%6.4%6.7 $6.66
11/15/20231,280,000 shares $8.68 million -9.2%6.8%6.8 $6.78
10/31/20231,410,000 shares $10.90 million -22.1%7.9%6.6 $7.73
10/15/20231,810,000 shares $16.40 million -1.1%10.2%9.7 $9.06
9/30/20231,830,000 shares $17.40 million +3.4%10.3%9.9 $9.51
9/15/20231,770,000 shares $20.37 million +18.8%9.9%8.8 $11.51
8/31/20231,490,000 shares $19.13 million +2.8%8.0%7 $12.84
8/15/20231,450,000 shares $18.08 million +25.0%7.8%7.4 $12.47
7/31/20231,160,000 shares $16.39 million +0.9%6.2%7 $14.13
7/15/20231,150,000 shares $17.85 million +12.8%7.4%7.6 $15.52
6/30/20231,020,000 shares $17.39 million +47.0%6.6%6.8 $17.05
6/15/2023693,900 shares $10.81 million +12.5%4.5%4.9 $15.58
5/31/2023616,800 shares $8.97 million -16.4%4.0%3.7 $14.54
5/15/2023738,000 shares $11.95 million No Change4.8%4.3 $16.19

MLYS Short Interest - Frequently Asked Questions

What is Mineralys Therapeutics' current short interest?

Short interest is the volume of Mineralys Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 850,500 shares of MLYS short. 4.82% of Mineralys Therapeutics' shares are currently sold short. Learn More on Mineralys Therapeutics' current short interest.

What is a good short interest ratio for Mineralys Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MLYS shares currently have a short interest ratio of 5.0. Learn More on Mineralys Therapeutics's short interest ratio.

Which institutional investors are shorting Mineralys Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mineralys Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Mineralys Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.82% of Mineralys Therapeutics' floating shares are currently sold short.

Is Mineralys Therapeutics' short interest increasing or decreasing?

Mineralys Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 850,500 shares, an increase of 1.0% from the previous total of 842,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Mineralys Therapeutics' float size?

Mineralys Therapeutics currently has issued a total of 49,630,000 shares. Some of Mineralys Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mineralys Therapeutics currently has a public float of 17,660,000 shares.

How does Mineralys Therapeutics' short interest compare to its competitors?

4.82% of Mineralys Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Mineralys Therapeutics: Calliditas Therapeutics AB (publ) (0.01%), SIGA Technologies, Inc. (12.77%), Olema Pharmaceuticals, Inc. (14.48%), Lyell Immunopharma, Inc. (15.53%), CureVac (5.47%), Cogent Biosciences, Inc. (11.34%), Longboard Pharmaceuticals, Inc. (14.91%), Pharming Group (0.00%), Korro Bio, Inc. (2.31%), Astria Therapeutics, Inc. (11.37%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Mineralys Therapeutics stock?

Short selling MLYS is an investing strategy that aims to generate trading profit from Mineralys Therapeutics as its price is falling. MLYS shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Mineralys Therapeutics?

A short squeeze for Mineralys Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MLYS, which in turn drives the price of the stock up even further.

How often is Mineralys Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MLYS, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:MLYS) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners